Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Mechanisms of Resistance

Characterization of TEM-56, a Novel β-Lactamase Produced by a Klebsiella pneumoniae Clinical Isolate

Catherine Neuwirth, Roger Labia, Eliane Siebor, Andre Pechinot, Stephanie Madec, El Bachir Chaibi, Antoine Kazmierczak
Catherine Neuwirth
Laboratoire de Bactériologie, Hôpital Universitaire du Bocage, B.P. 1542, 21034 Dijon Cedex, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roger Labia
Centre National de la Recherche Scientifique, UMR175, 6 rue de l'Université, 29000 Quimper, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eliane Siebor
Laboratoire de Bactériologie, Hôpital Universitaire du Bocage, B.P. 1542, 21034 Dijon Cedex, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andre Pechinot
Laboratoire de Bactériologie, Hôpital Universitaire du Bocage, B.P. 1542, 21034 Dijon Cedex, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephanie Madec
Centre National de la Recherche Scientifique, UMR175, 6 rue de l'Université, 29000 Quimper, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
El Bachir Chaibi
Centre National de la Recherche Scientifique, UMR175, 6 rue de l'Université, 29000 Quimper, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antoine Kazmierczak
Laboratoire de Bactériologie, Hôpital Universitaire du Bocage, B.P. 1542, 21034 Dijon Cedex, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/AAC.44.2.453-455.2000
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

TEM-56 produced by a Klebsiella pneumoniae clinical isolate is a novel β-lactamase of isoelectric point 6.4 that confers a moderate resistance level to expanded-spectrum cephalosporins. The amino acid sequence deduced from the corresponding bla gene showed two amino acid replacements with respect to the TEM-2 sequence: Glu-104 to Lys and His-153 to Arg. This enzyme showed catalytic properties close to those of TEM-18. Thus, TEM-56 appears as a new TEM mutant, an intermediary between TEM-18 and the extended-spectrum β-lactamase TEM-21.

In Dijon University Hospital, Dijon, France, Klebsiella pneumoniae isolates with decreased susceptibility to cephalosporins or aztreonam are submitted to epidemiological studies performed by analytical isoelectric focusing and pulsed-field gel electrophoresis (8, 14, 17). Over a 2-year period (1995 to 1996), 22 strains producing a β-lactamase of pI 6.4 were isolated. Analysis of chromosomal DNA by pulsed-field gel electrophoresis revealed that the 22 strains were closely related according to Tenover's criteria (24). For 21 of them, a double-disk synergy test (11) was positive between clavulanic acid and cefotaxime, whereas it was considered negative for strain Kp 395. The MICs for β-lactams of strains of the first group were similar, whereas those for the last strain differed. Kp 395 showed high MICs for penicillins and cephalothin, but the MICs were low for expanded-spectrum cephalosporins and aztreonam and similar to those seen for Escherichia coli strains producing TEM-18 (Table1). Conversely, MICs for these agents against Kp 377 (one representative strain of the first group) were comparable to those for the TEM-3-producing strain. Clavulanic acid potentiated expanded-spectrum cephalosporins and aztreonam, but the MICs of penicillins remained high.

View this table:
  • View inline
  • View popup
Table 1.

MICs for K. pneumoniae clinical isolates Kp 395 and Kp 377 and E. coli strains producing TEM-18, TEM-2, or TEM-3

For Kp 395 and Kp 377, a plasmid of 120 kb was extracted by the method of Birnboim and Doly (4), but all conjugation experiments carried to transfer resistance failed. Transformation experiments using E. coli HB 101 or E. coliDH5a competent cells failed, too. PCR analysis was performed as described previously (16) on plasmid DNA extracted from both strains with primers J (forward, 5′-CTTATTCCCTTTTTTGCGGC-3′) and E (reverse, 5′-GGTCTGACAGTTACCAATGC-3′) (6) at positions 236 and 1079 of the TEM family gene β-lactamase, respectively, with numbering according to Sutcliffe (23). The promoter region was amplified with the following primers: GOV1 (forward, 5′-ATAAAATTCTTGAAGACGAAA-3′) (16) and SIE2 (reverse, 5′-AAAACTCTCAAGGATCTTACC-3′) (this study) at positions −5 and 380, respectively. PCR products were sequenced with an Applied Biosystems 373A sequencer according to the manufacturer's instructions. Analysis of the sequences (Table2) revealed that the twoblaTEM genes were derived fromblaTEM-2. Moreover, their promoter regions are identical to that of blaTEM-2.

View this table:
  • View inline
  • View popup
Table 2.

Nucleotide substitutions inblaTEM-2, blaTEM-21, and blaTEM-56 genes

The deduced amino acid sequences of the enzymes produced by Kp 377 and Kp 395 are reported in Table 3. The enzyme produced by Kp 377 was TEM-21 of pI 6.4 (Lys-39, Lys-104, Arg-153, and Ser-238) (2, 3, 25) and that produced by Kp 395 was a new enzyme: TEM-56 of pI 6.4 also (Lys-39, Lys-104, and Arg-153). It appears that TEM-18 (Lys-39 and Lys-104) (R. Labia and D. Sirot, personal communication), TEM-56, and TEM-3 (Lys-39, Lys-104, and Ser-238) are intermediate mutants between TEM-2 and TEM-21. Within the TEM family, Arg-153 has been found only in TEM-21 and TEM-56.

View this table:
  • View inline
  • View popup
Table 3.

Comparative kinetic parameters of β-lactamase TEM-2 and its mutants

β-Lactamases TEM-2, TEM-18, TEM-56, TEM-3, and TEM-21 were purified to homogeneity according to previously described methods using ammonium sulfate precipitation, ion-exchange chromatography, and size exclusion chromatography (7, 15). Kinetic constants (Table 3) were determined by computerized microacidimetry (13), at pH 7 and 37°C, in distilled water containing 85 mM NaCl. TEM-56 hydrolyzed ceftriaxone and cefotaxime moderately, but the action on cefuroxime and ceftazidime was hardly detectable, a situation very similar to that of TEM-18. Concerning penicillins, the kinetics of TEM-56 and TEM-18 were comparable to those of TEM-2. TEM-21 and TEM-3 had considerable activity for expanded-spectrum cephalosporins and low Kmvalues for penicillins. TEM-56, TEM-21, TEM-18, and TEM-3 enzymes are susceptible to β-lactamase inhibitors and, in some instances, more so than native TEM-2 (Table 4). Aztreonam was a poor substrate for all tested β-lactamases (data not shown).

View this table:
  • View inline
  • View popup
Table 4.

50% inhibitory concentrations (IC50s) of β-lactamase inhibitors for β-lactamase TEM-2 and its mutants

TEM-18 and TEM-56 gave similar and moderate decreases in susceptibility levels of cefotaxime, ceftazidime, and aztreonam. On the contrary, TEM-21 and TEM-3 conferred a high level of resistance to expanded-spectrum cephalosporins. This indicates that the Glu-104 to Lys amino acid substitution enables the mutant to hydrolyze these cephalosporins but not enough to confer a true resistance, as already noticed in the variants obtained by site-directed mutagenesis (18, 20, 22, 27). Conversely, the substitution of Gly-238 for Ser has a key role, as already demonstrated (5, 21, 26). Concerning the His-153 for Arg amino acid substitution, comparison of TEM-56 and TEM-18, on one hand, and TEM-21 and TEM-3, on the other hand, shows that this substitution does not significantly modify the hydrolytic properties of the enzyme, as also shown by enzyme kinetics.

Comparison of a large set of class A β-lactamase sequences (12, 19) shows that residue 153 is not conserved, but the most frequently encountered is arginine. The role of the His-153 for Arg amino acid substitution remains unclear. Often, extended-spectrum or inhibitor-resistant TEM-derived β-lactamases may present one or a few secondary amino acid substitutions whose roles are not always elucidated. Within presently reported TEM mutant β-lactamases, about 10 positions have been described (http://www.lahey.org/studies/webt.htm).

It is noteworthy that the first of the 22 strains producing an enzyme of pI 6.4 was Kp 395, producing TEM-56. This strain was isolated from a patient who had received multiple β-lactam therapies, and TEM-56 was detected only once. Then Kp 377, producing TEM-21, was isolated from a patient in the same ward. This suggests thatblaTEM-21, which differs fromblaTEM-56 by a single base at position 914, was selected under antibiotic pressure in vivo. Then the strain spread in the ward and in other departments subsequent to patients' transfers.

ACKNOWLEDGMENTS

C.N. and R.L. contributed equally to this work.

FOOTNOTES

    • Received 10 May 1999.
    • Returned for modification 18 August 1999.
    • Accepted 5 November 1999.
  • Copyright © 2000 American Society for Microbiology

REFERENCES

  1. 1.
    1. Ambler R. P.,
    2. Coulson A. F. W.,
    3. Frère J. M.,
    4. Ghuysen J. M.,
    5. Joris B.,
    6. Forsman M.,
    7. Levesque R. C.,
    8. Tirabi G.,
    9. Waley S. G.
    A standard numbering scheme for the class A β-lactamases. Biochem. J. 276 1991 269 272
    OpenUrlFREE Full Text
  2. 2.↵
    1. Arlet G.,
    2. Brami G.,
    3. Decré D.,
    4. Filippo A.,
    5. Gaillot O.,
    6. Lagrange P. H.,
    7. Philippon A.
    Molecular characterisation by PCR-restriction fragment length polymorphism of TEM β-lactamases. FEMS Microbiol. Lett. 134 1995 203 208
    OpenUrlPubMedWeb of Science
  3. 3.↵
    1. Arlet G.,
    2. Goussard S.,
    3. Courvalin P.,
    4. Philippon A.
    Sequences of the genes for the TEM-20, TEM-21, TEM-22, and TEM-29 extended-spectrum beta-lactamases. Antimicrob. Agents Chemother. 43 1999 969 971
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Birnboim H. C.,
    2. Doly J.
    Rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res. 7 1979 1513 1523
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. Cantu C. III,
    2. Huang W.,
    3. Palzkill T.
    Selection and characterization of amino acid substitutions at residues 237-240 of TEM-1 β-lactamase with altered substrate specificity for aztreonam and ceftazidime. J. Biol. Chem. 271 1996 22538 22545
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Chanal C.,
    2. Poupart M. C.,
    3. Sirot D.,
    4. Labia R.,
    5. Sirot J.,
    6. Cluzel R.
    Nucleotide sequences of CAZ-2, CAZ-6, and CAZ-7 β-lactamase genes. Antimicrob. Agents Chemother. 36 1992 1817 1820
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Farzaneh S.,
    2. Chaibi E. B.,
    3. Péduzzi J.,
    4. Barthélémy M.,
    5. Labia R.,
    6. Blazquez J.,
    7. Baquero F.
    Implication of Ile-69 and Thr-182 residues in kinetic characteristics of IRT-3 (TEM-32) β-lactamase. Antimicrob. Agents Chemother. 40 1996 2434 2436
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Gouby A.,
    2. Neuwirth C.,
    3. Bourg G.,
    4. Bouzigues N.,
    5. Carles-Nurit M. J.,
    6. Despaux E.,
    7. Ramuz M.
    Epidemiological study by pulsed-field gel electrophoresis of an outbreak of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in a geriatric hospital. J. Clin. Microbiol. 32 1994 301 305
    OpenUrlAbstract/FREE Full Text
  9. 9.
    1. Goussard S.,
    2. Courvalin P.
    Sequence of the genes blaT-1B and blaT-2. Gene 102 1991 71 73
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.
    1. Heffron F.,
    2. McCarty B. J.,
    3. Ohtsubo H.,
    4. Ohtsubo E.
    DNA sequence analysis of the transposon tn3: three genes and three sites involved in transposition of tn3. Cell 18 1979 1153 1163
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    1. Jarlier V.,
    2. Nicolas M. H.,
    3. Fournier G.,
    4. Philippon A.
    Extended broad-spectrum β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev. Infect. Dis. 10 1988 867 878
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    1. Joris B.,
    2. Ledent P.,
    3. Dideberg O.,
    4. Fonzé E.,
    5. Lamotte-Brasseur J.,
    6. Kelly J. A.,
    7. Ghuysen J. M.,
    8. Frère J. M.
    Comparison of the sequences of class A β-lactamases and of the secondary structure elements of penicillin-recognizing proteins. Antimicrob. Agents Chemother. 35 1991 2294 2301
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Labia R.,
    2. Andrillon J.,
    3. Le Goffic F.
    Computerized microacidimetric determination of beta-lactamase Michaelis-Menten constants. FEBS Lett. 33 1973 42 44
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    1. Labia R.,
    2. Barthélémy M.,
    3. Masson J. M.
    Multiplicité des β-lactamases: un problème d'isoenzymes? C. R. Acad. Sci. (Paris) 283D 1976 1597 1600
    OpenUrl
  15. 15.↵
    1. Lenfant F.,
    2. Labia R.,
    3. Masson J. M.
    Replacement of lysine 234 affects transition state stabilization in the active site of β-lactamase TEM1. J. Biol. Chem. 266 1991 17187 17194
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Mabilat C.,
    2. Goussard S.
    PCR detection and identification of genes for extended-spectrum β-lactamases Diagnostic molecular microbiology: principles and applications. Persing D. H., Smith T. F., Tenover F. C., White T. J. 1993 553 563 American Society for Microbiology Washington, D.C.
  17. 17.↵
    1. Neuwirth C.,
    2. Siébor E.,
    3. Lopez J.,
    4. Péchinot A.,
    5. Kazmierczak A.
    Outbreak of TEM-24-producing Enterobacter aerogenes in an intensive care unit and dissemination of the extended-spectrum β-lactamase to other members of the family Enterobacteriaceae. J. Clin. Microbiol. 34 1996 76 79
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    1. Palzkill T.,
    2. Botstein D.
    Identification of amino acid substitutions that alter the substrate specificity of TEM-1 β-lactamase. J. Bacteriol. 174 1992 5237 5243
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    1. Péduzzi J.,
    2. Reynaud A.,
    3. Baron P.,
    4. Barthélémy M.,
    5. Labia R.
    Chromosomally encoded cephalosporinase of Proteus vulgaris Ro104 belongs to Ambler's class A. Biochim. Biophys. Acta 1207 1994 31 39
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Petit A.,
    2. Maveyraud L.,
    3. Lenfant F.,
    4. Samama J. P.,
    5. Labia R.,
    6. Masson J. M.
    Multiple substitutions at position 104 of β-lactamase TEM-1: assessing the role of this residue in substrate specificity. Biochem. J. 305 1995 33 40
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    1. Saves I.,
    2. Burlet-Schilt I.,
    3. Maveyraud L.,
    4. Samama J. P.,
    5. Promé J. C.,
    6. Masson J. M.
    Mass spectral kinetic study of acylation and deacylation during the hydrolysis of penicillins and cefotaxime by β-lactamase TEM-1 and the G238S mutant. Biochemistry 34 1995 11660 11667
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Sowek J. A.,
    2. Singer S. B.,
    3. Ohringer S.,
    4. Malley M. F.,
    5. Dougherty T. J.,
    6. Gougoutas J. Z.,
    7. Bush K.
    Substitution of lysine at position 104 or 240 of TEM-1 pTS18R β-lactamase enhances the effect of serine-164 substitution on hydrolysis or affinity for cephalosporins and the monobactam aztreonam. Biochemistry 30 1991 3179 3188
    OpenUrlCrossRefPubMed
  23. 23.↵
    1. Sutcliffe J. G.
    Nucleotide sequence of the ampicillin resistance gene of Escherichia coli plasmid pBR322. Proc. Natl. Acad. Sci. USA 8 1978 3737 3741
    OpenUrl
  24. 24.↵
    1. Tenover F. C.,
    2. Arbeit R. D.,
    3. Goering R. V.,
    4. Mickelsen P. A.,
    5. Murray B. E.,
    6. Persing D. H.,
    7. Swaminathan B.
    Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33 1995 2233 2239
    OpenUrlFREE Full Text
  25. 25.↵
    1. Tessier F.,
    2. Arpin C.,
    3. Allery A.,
    4. Quentin C.
    Molecular characterization of a TEM-21 β-lactamase in a clinical isolate of Morganella morganii. Antimicrob. Agents Chemother. 42 1998 2125 2127
    OpenUrlAbstract/FREE Full Text
  26. 26.↵
    1. Venkatachalam K. V.,
    2. Huang W.,
    3. La Rocco M.,
    4. Palzkill T.
    Characterization of TEM-1 β-lactamase mutants from position 238 to 241 with increased catalytic efficiency for ceftazidime. J. Biol. Chem. 269 1994 23444 23450
    OpenUrlAbstract/FREE Full Text
  27. 27.↵
    1. Viadiu H.,
    2. Osuna J.,
    3. Fink A. L.,
    4. Soberon X.
    A new TEM β-lactamase double mutant with broadened specificity reveals substrate-dependent functional interactions. J. Biol. Chem. 270 1995 781 787
    OpenUrlAbstract/FREE Full Text
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
Characterization of TEM-56, a Novel β-Lactamase Produced by a Klebsiella pneumoniae Clinical Isolate
Catherine Neuwirth, Roger Labia, Eliane Siebor, Andre Pechinot, Stephanie Madec, El Bachir Chaibi, Antoine Kazmierczak
Antimicrobial Agents and Chemotherapy Feb 2000, 44 (2) 453-455; DOI: 10.1128/AAC.44.2.453-455.2000

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Characterization of TEM-56, a Novel β-Lactamase Produced by a Klebsiella pneumoniae Clinical Isolate
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Characterization of TEM-56, a Novel β-Lactamase Produced by a Klebsiella pneumoniae Clinical Isolate
Catherine Neuwirth, Roger Labia, Eliane Siebor, Andre Pechinot, Stephanie Madec, El Bachir Chaibi, Antoine Kazmierczak
Antimicrobial Agents and Chemotherapy Feb 2000, 44 (2) 453-455; DOI: 10.1128/AAC.44.2.453-455.2000
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Klebsiella pneumoniae
beta-lactamases

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596